by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2
Hypercoagulability and COVID-19 Infection Alciona SASU, Cristina FIRU, Alexandra NADABAN, Adelina PALCU, Daniel PAPIU, Anca HERMENEAN, Coralia Adina COTORACI COVID-19 is a relatively recent and clinically heterogeneous infection, with a broad spectrum of...
by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2
Prognostic Significance of Neutrophil to Lymphocyte Ratio in Multiple Myeloma Patient Daniela DIACONESCU, Ana-Maria ILINESCU, Claudiu Dragos POPESCU, Dan Sebastian SOARE, Georgiana ENE, Horia BUMBEA Multiple myeloma represents a hematologic malignancy...
by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2
A Retrospective Analysis of CLL Patients in a Romanian Hematology Center Ana-Maria IORDAN, Minodora Cezarina ONISAI, Anca RAITARU, Claudia DESPAN, Ionel GELATU, Silvia CIORTAN, Daniela GEORGESCU Background: Chronic lymphocytic leukemia (CLL) is the most common...
by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2
The Benefit of Brentuximab Vedotin and Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma: A Single-Center Retrospective Study Diana-Marina FORTOES, Elena NICORICI, Cosmin MINCIUNA Andrei CIANGA, Ramona TIMOFTE, Amalia TITIEANU, Elena DOLACHI-PELIN, Ion...
by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2
Clinical Diversity and Treatment Outcomes in IgM Monoclonal Gammopathy Associated with Cold Agglutinin Disease and Cryoglobulinemia: A Single Center Study Larisa ZIDARU, Sinziana BARBU, Ruxandra DRAGHICI, Sebastian Nicolae TIMOTEI, Daniel CORIU, Sorina Nicoleta...
